Use of clostridium leptum strain for prevention, treatment, and diagnosis of inflammatory bowel disease

WO2025244478A1PCT designated stage Publication Date: 2025-11-27SEOUL NAT UNIV HOSPITAL +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2025/007094
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-24
Filing Date
2025-05-26
Publication Date
2025-11-27

Smart Images

  • Figure KR2025007094_27112025_PF_FP_ABST
    Figure KR2025007094_27112025_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a novel microorganism and a use thereof for preventing, alleviating, or treating intestinal diseases. The strain according to one embodiment has effects of inhibiting intestinal atrophy and reducing bloody stools, and thus is useful for the prevention, amelioration, or treatment of intestinal diseases. In addition, since the strain is significantly reduced in the patient group, the strain can be used for early diagnosis of intestinal diseases or selection of a risk group.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Crohn's disease (CD) related microbial marker set and application thereof

    CN112111586A

  • Conference mediation method

    KR1020220053952A

  • Clostridium leptum strain, and vesicles from thereof and anti-inflammation and anti-bacteria uses of thereof

    KR102337993B1

  • Probiotic recolonisation therapy

    US20190290704A1